
The global Lancing Devices market size is predicted to grow from US$ 360 million in 2025 to US$ 479 million in 2031; it is expected to grow at a CAGR of 4.9% from 2025 to 2031.
Lancing device is an instrument equipped with a lancet. It is also most commonly used by diabetics during blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for fetal scalp blood testing to get a measure of the acid base status of the fetus.
The lancing device is a convenient medical tool for collecting capillary blood samples for glucose monitoring or other tests requiring one or two drops of blood. It is dedicated for home diagnostics and aimed to be used by patients when performing skin puncture on them. A convenient and effortless device specially designed for the highest comfort in daily diabetes management.
Global Lancing Devices key players include Roche, Lifescan, Abbott, Ascensia, B. Braun , etc. Global top five manufacturers hold a share over 40%.
Americas is the largest market, with a share about 40%, followed by APAC, Europe, both have a share about 45 percent. In terms of product, Adjustable Lancing Device is the largest segment, with a share over 95%. And in terms of application, the largest application is Glucose Tests, followed by Cholesterol Tests.
The “Lancing Devices Industry Forecast” looks at past sales and reviews total world Lancing Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Lancing Devices sales for 2025 through 2031. With Lancing Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lancing Devices industry.
This Insight Report provides a comprehensive analysis of the global Lancing Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lancing Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lancing Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lancing Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lancing Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Lancing Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Adjustable Lancing Device
Non-adjustable Lancing Device
Segmentation by Application:
Glucose Tests
Cholesterol Tests
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lancing Devices market?
What factors are driving Lancing Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lancing Devices market opportunities vary by end market size?
How does Lancing Devices break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lancing Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lancing Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lancing Devices by Country/Region, 2020, 2024 & 2031
2.2 Lancing Devices Segment by Type
2.2.1 Adjustable Lancing Device
2.2.2 Non-adjustable Lancing Device
2.3 Lancing Devices Sales by Type
2.3.1 Global Lancing Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Lancing Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lancing Devices Sale Price by Type (2020-2025)
2.4 Lancing Devices Segment by Application
2.4.1 Glucose Tests
2.4.2 Cholesterol Tests
2.4.3 Others
2.5 Lancing Devices Sales by Application
2.5.1 Global Lancing Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Lancing Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Lancing Devices Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Lancing Devices Breakdown Data by Company
3.1.1 Global Lancing Devices Annual Sales by Company (2020-2025)
3.1.2 Global Lancing Devices Sales Market Share by Company (2020-2025)
3.2 Global Lancing Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Lancing Devices Revenue by Company (2020-2025)
3.2.2 Global Lancing Devices Revenue Market Share by Company (2020-2025)
3.3 Global Lancing Devices Sale Price by Company
3.4 Key Manufacturers Lancing Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lancing Devices Product Location Distribution
3.4.2 Players Lancing Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Lancing Devices by Geographic Region
4.1 World Historic Lancing Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Lancing Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lancing Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lancing Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Lancing Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lancing Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lancing Devices Sales Growth
4.4 APAC Lancing Devices Sales Growth
4.5 Europe Lancing Devices Sales Growth
4.6 Middle East & Africa Lancing Devices Sales Growth
5 Americas
5.1 Americas Lancing Devices Sales by Country
5.1.1 Americas Lancing Devices Sales by Country (2020-2025)
5.1.2 Americas Lancing Devices Revenue by Country (2020-2025)
5.2 Americas Lancing Devices Sales by Type (2020-2025)
5.3 Americas Lancing Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lancing Devices Sales by Region
6.1.1 APAC Lancing Devices Sales by Region (2020-2025)
6.1.2 APAC Lancing Devices Revenue by Region (2020-2025)
6.2 APAC Lancing Devices Sales by Type (2020-2025)
6.3 APAC Lancing Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lancing Devices by Country
7.1.1 Europe Lancing Devices Sales by Country (2020-2025)
7.1.2 Europe Lancing Devices Revenue by Country (2020-2025)
7.2 Europe Lancing Devices Sales by Type (2020-2025)
7.3 Europe Lancing Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lancing Devices by Country
8.1.1 Middle East & Africa Lancing Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lancing Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Lancing Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Lancing Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lancing Devices
10.3 Manufacturing Process Analysis of Lancing Devices
10.4 Industry Chain Structure of Lancing Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lancing Devices Distributors
11.3 Lancing Devices Customer
12 World Forecast Review for Lancing Devices by Geographic Region
12.1 Global Lancing Devices Market Size Forecast by Region
12.1.1 Global Lancing Devices Forecast by Region (2026-2031)
12.1.2 Global Lancing Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lancing Devices Forecast by Type (2026-2031)
12.7 Global Lancing Devices Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Lancing Devices Product Portfolios and Specifications
13.1.3 Roche Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Lifescan
13.2.1 Lifescan Company Information
13.2.2 Lifescan Lancing Devices Product Portfolios and Specifications
13.2.3 Lifescan Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Lifescan Main Business Overview
13.2.5 Lifescan Latest Developments
13.3 Abbott
13.3.1 Abbott Company Information
13.3.2 Abbott Lancing Devices Product Portfolios and Specifications
13.3.3 Abbott Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Abbott Main Business Overview
13.3.5 Abbott Latest Developments
13.4 Ascensia
13.4.1 Ascensia Company Information
13.4.2 Ascensia Lancing Devices Product Portfolios and Specifications
13.4.3 Ascensia Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Ascensia Main Business Overview
13.4.5 Ascensia Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Lancing Devices Product Portfolios and Specifications
13.5.3 B. Braun Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 TERUMO
13.6.1 TERUMO Company Information
13.6.2 TERUMO Lancing Devices Product Portfolios and Specifications
13.6.3 TERUMO Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 TERUMO Main Business Overview
13.6.5 TERUMO Latest Developments
13.7 Sinocare
13.7.1 Sinocare Company Information
13.7.2 Sinocare Lancing Devices Product Portfolios and Specifications
13.7.3 Sinocare Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sinocare Main Business Overview
13.7.5 Sinocare Latest Developments
13.8 ARKRAY
13.8.1 ARKRAY Company Information
13.8.2 ARKRAY Lancing Devices Product Portfolios and Specifications
13.8.3 ARKRAY Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 ARKRAY Main Business Overview
13.8.5 ARKRAY Latest Developments
13.9 GMMC Group
13.9.1 GMMC Group Company Information
13.9.2 GMMC Group Lancing Devices Product Portfolios and Specifications
13.9.3 GMMC Group Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GMMC Group Main Business Overview
13.9.5 GMMC Group Latest Developments
13.10 BIONIME
13.10.1 BIONIME Company Information
13.10.2 BIONIME Lancing Devices Product Portfolios and Specifications
13.10.3 BIONIME Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 BIONIME Main Business Overview
13.10.5 BIONIME Latest Developments
13.11 LIANFA
13.11.1 LIANFA Company Information
13.11.2 LIANFA Lancing Devices Product Portfolios and Specifications
13.11.3 LIANFA Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 LIANFA Main Business Overview
13.11.5 LIANFA Latest Developments
13.12 Lobeck Medical AG
13.12.1 Lobeck Medical AG Company Information
13.12.2 Lobeck Medical AG Lancing Devices Product Portfolios and Specifications
13.12.3 Lobeck Medical AG Lancing Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Lobeck Medical AG Main Business Overview
13.12.5 Lobeck Medical AG Latest Developments
14 Research Findings and Conclusion
*If Applicable.
